These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function. Hart DA; Rehemtulla A Comp Biochem Physiol B; 1988; 90(4):691-708. PubMed ID: 2854764 [No Abstract] [Full Text] [Related]
3. Hormone regulation of tissue-type plasminogen activator gene expression and plasminogen activator-mediated proteolysis. Ohlsson M; Peng XR; Liu YX; Jia XC; Hsueh AJ; Ny T Semin Thromb Hemost; 1991 Jul; 17(3):286-90. PubMed ID: 1796299 [No Abstract] [Full Text] [Related]
4. Urokinase receptor is a key player in tumour progression. Taniguchi T; Lemoine NR; Kakkar AK Gut; 1998 Dec; 43(6):739-40. PubMed ID: 9824595 [No Abstract] [Full Text] [Related]
5. The plasminogen activation system in inflammation. Del Rosso M; Fibbi G; Pucci M; Margheri F; Serrati S Front Biosci; 2008 May; 13():4667-86. PubMed ID: 18508538 [TBL] [Abstract][Full Text] [Related]
6. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis. Beal MF Exp Neurol; 2008 Jun; 211(2):332-3. PubMed ID: 18423450 [No Abstract] [Full Text] [Related]
7. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor. Hollas W; Boyd D Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585 [No Abstract] [Full Text] [Related]
8. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action. Gurewich V Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884 [No Abstract] [Full Text] [Related]
9. [The structure and function of urokinase receptor and its expression in neoplastic tissues]. Tang H; Zhu Y; Song H Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):315-7. PubMed ID: 7656166 [No Abstract] [Full Text] [Related]
10. Plasminogen activation in healing human wounds. Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators and inhibitor type-1 in alveolar osteitis. Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Chapman HA Curr Opin Cell Biol; 1997 Oct; 9(5):714-24. PubMed ID: 9330876 [TBL] [Abstract][Full Text] [Related]
13. [Plasminogen activators in tumor tissue]. Tomasiuk R; Mirowski M; Wierzbicki R Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455 [No Abstract] [Full Text] [Related]
14. Role of urokinase, its receptor, and serpins in colorectal carcinoma. Jessup JM Gastroenterology; 1994 Nov; 107(5):1555-9. PubMed ID: 7926521 [No Abstract] [Full Text] [Related]
15. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator. Kindzelskii AL; Amhad I; Keller D; Zhou MJ; Haugland RP; Garni-Wagner BA; Gyetko MR; Todd RF; Petty HR Histochem Cell Biol; 2004 Apr; 121(4):299-310. PubMed ID: 15042374 [TBL] [Abstract][Full Text] [Related]
16. Human plasminogen activators. Genes and proteins structure. Blasi F; Riccio A; Sebastio G Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360 [No Abstract] [Full Text] [Related]
17. Cellular receptors in the regulation of plasmin generation. Hajjar KA Thromb Haemost; 1995 Jul; 74(1):294-301. PubMed ID: 8578475 [TBL] [Abstract][Full Text] [Related]
18. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)]. Félez J; Rueda F Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250 [No Abstract] [Full Text] [Related]